A. Barbuti

Comprehensive Synthesis of Amino Acid-Derived Thiazole Peptidomimetic Analogues to Understand the Enigmatic Drug/Substrate-Binding Site of P-Glycoprotein.

Bhargav A. Patel, S. Ambudkar, Zhe-Sheng Chen, 2017, Journal of medicinal chemistry.

EGFR and HER2 Inhibitors as Sensitizing Agents for Cancer Chemotherapy

Zhe-Sheng Chen, Pranav Gupta, A. Barbuti, 2019, Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy.

MG53 inhibits cellular proliferation and tumor progression in colorectal carcinoma

Jianjie Ma, Tao Tan, P. Lin, 2022, International journal of biological sciences.

Plasma Anti-Glycan Antibody Profiles Associated with Nickel level in Urine

H. Pass, M. Vuskovic, K. Tchou-Wong, 2013, Journal of proteomics & bioinformatics.

A pilot study of low-cost contingency management to increase attendance in an adolescent substance abuse program.

A. Barbuti, C. Branson, P. Clemmey, 2012, The American journal on addictions.

Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy

Zhe-Sheng Chen, A. Barbuti, Anna Maria Barbuti, 2015, Cancers.

Preclinical development of a novel BCR-ABL T315I inhibitor against chronic myeloid leukemia.

Zhe-Sheng Chen, Dong-Hua Yang, K. Ding, 2019, Cancer letters.

Modulating the function of ATP‐binding cassette subfamily G member 2 (ABCG2) with inhibitor cabozantinib

Zhe-Sheng Chen, J. Wurpel, A. Barbuti, 2017, Pharmacological research.

Lipid–Saporin Nanoparticles for the Intracellular Delivery of Cytotoxic Protein to Overcome ABC Transporter-Mediated Multidrug Resistance In Vitro and In Vivo

Qiaobing Xu, Zhe-Sheng Chen, Ming Wang, 2020, Cancers.